Best Growth Stocks Ranked by Growth and Wall Street Score
Fast growth can create value, but growth purchased at an extreme valuation or funded with persistent dilution can disappoint shareholders. This list highlights companies with stronger reported revenue growth while keeping Wall Street Score visible as a broader quality check.
Current qualifying companies
These are the current highest-ranking companies that meet this page’s defined screen. The list is generated from validated Wall Street Score data and can change as company data and prices refresh.
- #1 Hotel101 Global Holdings Corp. (HBNB) — WSS 33/100 · Price $5.1 · Revenue Growth: 229.7%
- #2 Gaxos.ai Inc. (GXAI) — WSS 40/100 · Price $0.63 · Revenue Growth: 85.9%
- #3 Smart Logistics Global Limited Ordinary Shares (SLGB) — WSS 29/100 · Price $0.37 · Revenue Growth: 80.3%
- #4 ARS Pharmaceuticals, Inc. (SPRY) — WSS 20/100 · Price $4.5 · Revenue Growth: 52.0%
- #5 TDH Holdings, Inc. (PETZ) — WSS 46/100 · Price $1.37 · Revenue Growth: 39.7%
- #6 Keros Therapeutics, Inc. (KROS) — WSS 66/100 · Price $11.17 · Revenue Growth: 39.2%
- #7 Geron Corporation (GERN) — WSS 20/100 · Price $1.35 · Revenue Growth: 26.9%
- #8 Mega Matrix Corp. (MPU) — WSS 37/100 · Price $3.24 · Revenue Growth: 22.4%
- #9 QT Imaging Holdings, Inc. (QTI) — WSS 25/100 · Price $2.64 · Revenue Growth: 20.7%
- #10 Rezolve AI PLC (RZLV) — WSS 27/100 · Price $2.29 · Revenue Growth: 17.0%
- #11 Septerna Inc (SEPN) — WSS 36/100 · Price $38.44 · Revenue Growth: 16.4%
- #12 Viridian Therapeutics, Inc. (VRDN) — WSS 23/100 · Price $21.24 · Revenue Growth: 14.0%
- #13 Iovance Biotherapeutics, Inc. (IOVA) — WSS 33/100 · Price $8.6 · Revenue Growth: 13.9%
- #14 QXO, Inc. (QXO) — WSS 35/100 · Price $12.31 · Revenue Growth: 10.2%
- #15 VIDA Global Inc. (VIDA) — WSS 43/100 · Price $1.84 · Revenue Growth: 9.2%
- #16 Evaxion Biotech A/S (EVAX) — WSS 27/100 · Price $3.04 · Revenue Growth: 9.2%
- #17 Cellectis S.A. (CLLS) — WSS 17/100 · Price $1.82 · Revenue Growth: 8.8%
- #18 Kazia Therapeutics Ltd ADR (KZIA) — WSS 21/100 · Price $11.19 · Revenue Growth: 7.7%
- #19 ASP Isotopes Inc. Common Stock (ASPI) — WSS 31/100 · Price $3.15 · Revenue Growth: 6.4%
- #20 Joby Aviation, Inc. (JOBY) — WSS 33/100 · Price $6.39 · Revenue Growth: 6.2%
- #21 Immersion Corporation (IMMR) — WSS 37/100 · Price $7.4 · Revenue Growth: 6.1%
- #22 Autolus Therapeutics plc (AUTL) — WSS 22/100 · Price $1.88 · Revenue Growth: 5.7%
- #23 Lexicon Pharmaceuticals, Inc. (LXRX) — WSS 18/100 · Price $2.02 · Revenue Growth: 5.4%
- #24 Delcath Systems, Inc. (DCTH) — WSS 40/100 · Price $16.22 · Revenue Growth: 5.4%
- #25 Security National Financial Corporation (SNFCA) — WSS 77/100 · Price $8.79 · Revenue Growth: 5.0%
How this research list is built
Results require a current Wall Street Score and are sorted by reported revenue growth CAGR. Extreme or missing values are filtered in the presentation, and companies marked ineligible for public rankings are excluded.
How to use the ranking
Open the individual company pages behind the current ranking and compare the headline score with revenue, earnings, free cash flow, cash, debt, valuation, competitive position and company-specific risks. A screening result is a reason to research further, not a forecast.
Questions investors ask
The answers below explain how to interpret this screen and its limitations.
- What is a growth stock?
A growth stock is generally a company expected to expand revenue, earnings or cash flow faster than the broader market or its industry. - Why isn't the fastest-growing company automatically the best growth stock?
Growth quality matters. Valuation, margins, cash flow, debt, dilution and the durability of demand can all affect shareholder outcomes.
Continue your research
Educational research only. Rankings and scores are model outputs based on available data, not personalized investment advice or guarantees of future performance.